PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21536547-8	2011	In an ErbB2-driven breast tumor transgenic mouse model, the combination, but not single agent, treatment with triciribine and tipifarnib induces significant breast tumor regression.	triciribine	110-121	erb-b2 receptor tyrosine kinase 2	Mus musculus	6-11	
24452693-0	2014	Addition of the Akt inhibitor triciribine overcomes antibody resistance in cells from ErbB2/Neu-positive/PTEN-deficient mammary tumors.	triciribine	30-41	erb-b2 receptor tyrosine kinase 2	Mus musculus	86-91	
24452693-0	2014	Addition of the Akt inhibitor triciribine overcomes antibody resistance in cells from ErbB2/Neu-positive/PTEN-deficient mammary tumors.	triciribine	30-41	erb-b2 receptor tyrosine kinase 2	Mus musculus	92-95